Manufacturers Life Insurance Company, The Intercept Pharmaceuticals, Inc. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$9.99 - $18.71 $45,764 - $85,710	4,581 Added 44.03%	14,985 $277,000
Q2 2023 Aug 11, 2023	BUY	$9.17 - $19.29 $2,879 - $6,057	314 Added 3.11%	10,404 $115,000
Q3 2022 Aug 11, 2023	SELL	$12.21 - $19.7 $2,979 - $4,806	-244 Reduced 2.36%	10,090 $140,000
Q3 2022 Nov 03, 2022	SELL	$12.21 - $19.7 $2,979 - $4,806	-244 Reduced 2.36%	10,090 $141,000
Q2 2022 Aug 11, 2023	SELL	$11.23 - $19.59 $8,939 - $15,593	-796 Reduced 7.15%	10,334 $142,000
Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $8,939 - $15,593	-796 Reduced 7.15%	10,334 $143,000
Q1 2022 Aug 11, 2023	BUY	$13.37 - $17.79 $148,808 - $198,002	11,130 New	11,130 $181,000
Q1 2022 May 20, 2022	SELL	$13.37 - $17.79 $45,137 - $60,059	-3,376 Reduced 23.27%	11,130 $181,000
Q4 2021 Feb 16, 2022	SELL	$14.28 - $19.53 $21,405 - $29,275	-1,499 Reduced 9.37%	14,506 $236,000
Q3 2021 Nov 12, 2021	SELL	$12.99 - $20.47 $5,728 - $9,027	-441 Reduced 2.68%	16,005 $238,000
Q2 2021 Aug 12, 2021	BUY	$15.46 - $24.5 $15,645 - $24,794	1,012 Added 6.56%	16,446 $328,000
Q1 2021 May 03, 2021	SELL	$19.33 - $37.75 $7,094 - $13,854	-367 Reduced 2.32%	15,434 $356,000
Q4 2020 Feb 12, 2021	BUY	$24.48 - $42.47 $11,579 - $20,088	473 Added 3.09%	15,801 $390,000
Q3 2020 Nov 09, 2020	SELL	$39.09 - $53.44 $9,381 - $12,825	-240 Reduced 1.54%	15,328 $635,000
Q2 2020 Aug 10, 2020	SELL	$46.7 - $92.04 $26,805 - $52,830	-574 Reduced 3.56%	15,568 $727,000
Q1 2020 May 15, 2020	BUY	$48.35 - $118.68 $41,484 - $101,827	858 Added 5.61%	16,142 $1.02 Million
Q4 2019 Feb 14, 2020	SELL	$57.36 - $124.1 $16,978 - $36,733	-296 Reduced 1.9%	15,284 $1.89 Million
Q3 2019 Nov 12, 2019	BUY	$58.69 - $80.46 $6,690 - $9,172	114 Added 0.74%	15,580 $999,000
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $79,792 - $123,817	1,026 Added 7.11%	15,466 $1.23 Million
Q1 2019 May 13, 2019	BUY	$91.83 - $120.68 $94,125 - $123,697	1,025 Added 7.64%	14,440 $1.62 Million
Q4 2018 Feb 14, 2019	SELL	$85.79 - $126.46 $75,924 - $111,917	-885 Reduced 6.19%	13,415 $1.35 Million
Q3 2018 Nov 14, 2018	SELL	$88.49 - $127.55 $239,188 - $344,767	-2,703 Reduced 15.9%	14,300 $1.81 Million
Q2 2018 Aug 14, 2018	BUY	$60.0 - $85.67 $926,220 - $1.32 Million	15,437 Added 985.76%	17,003 $1.43 Million
Q1 2018 May 15, 2018	BUY	$52.72 - $67.25 $41,332 - $52,724	784 Added 100.26%	1,566 $96,000
Q4 2017 Feb 08, 2018	BUY	$58.2 - $72.76 $1,047 - $1,309	18 Added 2.36%	782 $46,000
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $43,555 - $90,725	764	764 $44,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account